InvestSMART

Clarity Pharmaceuticals Ltd (ASX: CU6) - Announcements

Current share price for CU6 : $1.380 0.09 (6.12%)+

ASX company news and announcements for Clarity Pharmaceuticals Ltd (CU6) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Clarity Pharmaceuticals Ltd (CU6) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Clarity Pharmaceuticals Ltd (CU6), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Clarity Pharmaceuticals Ltd (CU6)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$515 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2026 3:40PM $1.583 $1.380 fallen by 12.80%
$515 Ph III CLARIFY trial target number of participants achieved 27 Oct 2026 9:14AM $1.575 $1.380 fallen by 12.38%
$515 Notice of Annual General Meeting/Proxy Form 23 Oct 2026 10:39AM $1.578 $1.380 fallen by 12.52%
$515 Ceasing to be a substantial holder 20 Oct 2026 7:40PM $1.770 $1.380 fallen by 22.03%
$515 SAR-bisPSMA Presentation - Drug & Device Conference 13 Oct 2026 9:30AM $1.920 $1.380 fallen by 28.13%
$515 SECuRE update 8 Oct 2026 10:00AM $1.910 $1.380 fallen by 27.75%
$515 Becoming a substantial holder 5 Oct 2026 6:43PM $2.090 $1.380 fallen by 33.97%
$515 CORPORATE GOVERNANCE STATEMENT 30 Sep 2026 4:00PM $2.100 $1.380 fallen by 34.29%
$515 Appendix 4G 30 Sep 2026 3:52PM $2.105 $1.380 fallen by 34.44%
$515 Annual Report to shareholders 30 Sep 2026 3:45PM $2.115 $1.380 fallen by 34.75%
$515 Ceasing to be a substantial holder 24 Sep 2026 6:45PM $2.090 $1.380 fallen by 33.97%
$515 Becoming a substantial holder 22 Sep 2026 4:55PM $2.160 $1.380 fallen by 36.11%
$515 Date of Annual General Meeting 25 November 2026 21 Sep 2026 9:51AM $2.180 $1.380 fallen by 36.70%
$515 Preliminary Final Report 27 Aug 2026 12:32PM $2.490 $1.380 fallen by 44.58%
$515 Becoming a substantial holder 25 Aug 2026 8:03AM $2.390 $1.380 fallen by 42.26%
$515 Ceasing to be a substantial holder 12 Aug 2026 7:18PM $2.810 $1.380 fallen by 50.89%
$515 Becoming a substantial holder 7 Aug 2026 4:52PM $2.690 $1.380 fallen by 48.70%
$515 Ceasing to be a substantial holder 6 Aug 2026 5:58PM $2.680 $1.380 fallen by 48.51%
$515 Bioshares Biotech Summit Presentation 6 Aug 2026 9:57AM $2.700 $1.380 fallen by 48.89%
$515 Becoming a substantial holder 5 Aug 2026 6:24PM $2.700 $1.380 fallen by 48.89%
$515 Notification regarding unquoted securities - CU6 5 Aug 2026 4:55PM $2.700 $1.380 fallen by 48.89%
$515 SECuRE update 5 Aug 2026 10:00AM $2.620 $1.380 fallen by 47.33%
$515 Ceasing to be a substantial holder 31 Jul 2026 5:00PM $2.370 $1.380 fallen by 41.77%
$515 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2026 12:08PM $2.290 $1.380 fallen by 39.74%
$515 Becoming a substantial holder 30 Jul 2026 6:05PM $2.100 $1.380 fallen by 34.29%

1 - 25 of 524 results

Page 1 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.